Viral Clearance: Safety and Efficiency of Biopharmaceuticals.

Viral clearance is a vital procedure in the pharma industry, safeguarding the well-being of drug products by eradicating or inactivating possible viral toxins while manufacturing. This includes a multifaceted method, along with laborious testing of raw materials, process design, optimization, and va...

Descripción completa

Detalles Bibliográficos
Publicado en:Therapeutic Innovation & Regulatory Science Vol. 60; no. 3; pp. 663 - 674
Autores principales: Vahora, Shahin, Patel, Bhavesh, Talati, Nishant, Morker, Krupalkumar
Formato: pictorial review tables/charts Journal Article
Publicado: Springer Nature May2026
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=193278366&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 193278366
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        21684790
        FUHO
      jtl: Therapeutic Innovation & Regulatory Science
      issn: 21684790
      maglogo: N
    pubinfo:
      dt: May2026
      vid: 60
      iid: 3
      pid: 237
      pub: Springer Nature
      place: New York, New York
    artinfo:
      ui:
        193278366
        191511331
        193278366
        193278366
        10.1007/s43441-026-00922-2
        193278366
      ppf: 663
      ppct: 11
      formats:
      tig:
        atl: Viral Clearance: Safety and Efficiency of Biopharmaceuticals.
      aug:
        au:
          Vahora, Shahin
          Patel, Bhavesh
          Talati, Nishant
          Morker, Krupalkumar
        affil: Navinta LLC, 1499 Lower Ferry Road, 08618, Ewing, NJ, USA
      sug:
        subj:
          Drug Contamination Risk Factors
          Biological Products Analysis
          Patient Safety Evaluation
          Drug Efficacy Evaluation
          Viruses
          Drug Compounding
          Risk Assessment
          Drug Contamination Prevention and Control
          Legislation, Drug
          Chemistry, Pharmaceutical
          Pharmaceutical Companies
          Government Regulations
          Hydrogen-Ion Concentration
          Solvents
          Detergents
          Heating
          Chromatography
          Chemical Precipitation
      ab: Viral clearance is a vital procedure in the pharma industry, safeguarding the well-being of drug products by eradicating or inactivating possible viral toxins while manufacturing. This includes a multifaceted method, along with laborious testing of raw materials, process design, optimization, and validation studies to demonstrate the effectiveness of viral clearance steps. Nowadays, this topic has become more challenging and versatile with the development of new viruses in the environment. This manuscript focuses on the potential routes of viral contamination, including viral impurities present in the master cell bank, and contaminated virus introduced during manufacturing, adventitious viruses from raw materials, principles of viral clearance, regulatory framework, design of viral clearance studies interpretation and limitations, emerging technologies and trends, viral clearance strategies such as inactivation methods: low pH, solvent/detergent, heat treatment and removal methods like chromatography, nanofiltration, precipitation and related case studies.
      pubtype: Academic Journal
      doctype:
        pictorial
        review
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N